Welcome to invest
Rights Issue 2 - 16 June 2020

Merkintäoikeusanti 2.-18.6.2020

Investors/Läs mer

Sijoittajille

An easy-to-use
bone healing paste

Safer and better performing bone graft substitute

Read more

Latest news

Release 29.5.2020: The Prospectus of Rights Issue has been published on the Company’s website today Read more.

Release 26.5.2020: The Board of Directors of BBS-Bioactive Bone Substitutes Plc. decided on a subscription rights issue and publishes the prospectus and issue terms Read more.

Tiedote 26.5.2020: BBS-Bioactive Bone Substitutes Oyj:n hallitus päätti merkintäoikeusannista sekä julkistaa sen ehdot ja esitteen Lue lisää

18.5.2020: Haastattelussa First North-listan parhaiten tuottaneen osakkeen, BBS:n, johto Lue lisää.

Release 7.4.2020: The patent regarding the product ARTEBONE® has been granted in the USA Read more.

Release 19.02.2020: We are pleased to announce that the clinical result of ARTEBONE® is positive yielding an outcome similar to patient’s own bone graft Read more.

 

 
Certified
state-of-the-art
technology

Full preclinical safety and performance package as a medical device

Read more
Growing market for bone graft

Almost 3 million bone graft operations annually worldwide

Read more